Chapter 1. Ophthalmic Therapeutics/Drug Market- Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Ophthalmic Therapeutics/Drug Market- Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Ophthalmic Therapeutics/Drug Market- Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. Ophthalmic Therapeutics/Drug Market- Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 .Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Ophthalmic Therapeutics/Drug Market- Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Ophthalmic Therapeutics/Drug Market- By Type
6.1 Prescription Drugs
6.2 Over-the-counter Drugs
Chapter 7. Ophthalmic Therapeutics/Drug Market- By Dosage Form
7.1 Semisolid Ophthalmic Drug Forms
7.2 Multicompartment Drug Delivery Systems
7.3 Liquid Ophthalmic Drug Forms
7.4 Solid Ophthalmic Drug Forms
7.5 Others
Chapter 8. Ophthalmic Therapeutics/Drug Market- By Indication
8.1 Dry Eye
8.2 Glaucoma
8.3 Infection/Inflammation/Allergy
8.4 Retinal Disorders
8.5 Others
Chapter 9. Ophthalmic Therapeutics/Drug Market- By Therapeutic Class
9.1 Anti-inflammation
9.2 Anti-allergy
9.3 Anti-glaucoma
9.4 Anti-infection
9.5 Others
Chapter 10. Ophthalmic Therapeutics/Drug Market- By Distribution Channel
10.1 Drug Stores
10.2 Online Pharmacies
10.3 Hospital Pharmacies
10.4 Others
Chapter 11. Ophthalmic Therapeutics/Drug Market- By Region
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Latin America
11.5 The Middle East
11.6 Africa
Chapter 12. Ophthalmic Therapeutics/Drug Market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
12.1 Company 1
12.2 Company 2
12.3 Company 3
12.4 Company 4
12.5 Company 5
12.6 Company 6
12.7 Company 7
12.8 Company 8
12.9 Company 9
12.10 Company 10
2850
5250
4500
1800